1 Product identity
Ingredient risk
No flagged ingredients
Glucosamine Complex
BrandEnergyFirst→Non-Nutrient/Non-Botanical Tablet or Pill 13 ingredients DSLD #57734Net contents: 150 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2016-04-22
2 Ingredients (13)
IngredientGroupSafety
CaloriesCalories—
Total CarbohydratesCarbohydrate—
ProteinProtein (unspecified)—
CelluloseCellulose—
Stearic AcidStearic Acid—
GlycerinGlycerol—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Manganese — Conditionally Safe
⚠ Neurotoxicity with chronic excess
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Chondroitin — Limited Evidence
⚠ May enhance anticoagulants
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID57734
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2016-04-22
6 More from EnergyFirst
View EnergyFirst Safety Scorecard → 9 products
CLACo-Q10Men's Mega MultiOmegaEnergy OilOrganic FiberProbiotic Complex7 Cite this page
Vancouver
Pkhakadze G. Glucosamine Complex — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 19]. Available from: https://supplement.ge/products/glucosamine-complex-57734/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG